Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017129480) COLLAGEN TYPE VII ALPHA 1 ASSAY
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/129480 International Application No.: PCT/EP2017/051152
Publication Date: 03.08.2017 International Filing Date: 20.01.2017
IPC:
C07K 16/18 (2006.01) ,G01N 33/574 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
574
for cancer
Applicants:
NORDIC BIOSCIENCE A/S [DK/DK]; Herlev Hovedgade 207 DK-2730 Herlev, DK
Inventors:
SAND, Jannie, Marie, Bülow; DK
LEEMING, Diana, Julie; DK
KARSDAL, Morten; DK
Agent:
BECK GREENER; 12 Fulwood Place London WC1V 6HR, GB
Priority Data:
1601571.128.01.2016GB
Title (EN) COLLAGEN TYPE VII ALPHA 1 ASSAY
(FR) DOSAGE DU COLLAGÈNE DE TYPE VII ALPHA 1
Abstract:
(EN) A method of immunoassay for detecting in a biological sample a fragment of collagen type VII alpha 1 comprising an N- or C-terminal neo-epitope, the method comprising contacting the biological sample comprising the fragment of collagen type VII alpha 1 comprising the N- or C-terminal neo-epitope with an antibody of the invention, and determining the amount of binding of the antibody
(FR) L'invention concerne un procédé de dosage immunologique permettant de détecter, dans un échantillon biologique, un fragment de collagène de type VII alpha 1 comprenant un néo-épitope N- ou C-terminal, le procédé consistant à mettre en contact l'échantillon biologique comprenant le fragment de collagène de type VII alpha 1 comprenant le néo-épitope N- ou C-terminal avec un anticorps selon l'invention, et à déterminer la quantité de liaison de l'anticorps.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CA3007582KR1020180102647CN108602882EP3408289US20190195875